What are the appropriate indications for upper and lower gastrointestinal endoscopy and the most common diagnoses identified by these procedures?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 13, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Indications for Endoscopy and Common Diagnoses

Upper endoscopy should be performed for alarm symptoms (dysphagia, bleeding, anemia, weight loss, recurrent vomiting), GERD symptoms persisting despite 4-8 weeks of twice-daily PPI therapy, or in men >50 years with chronic GERD (>5 years) plus additional risk factors for Barrett esophagus; colonoscopy is indicated for screening, GI bleeding, iron deficiency anemia, and suspected inflammatory bowel disease. 1

Upper Endoscopy Indications

Clearly Appropriate Indications

Alarm symptoms - These mandate immediate upper endoscopy regardless of age or gender 1:

  • Dysphagia (progressive difficulty swallowing)
  • GI bleeding (hematemesis, melena)
  • Anemia (unexplained iron deficiency)
  • Unintentional weight loss
  • Recurrent vomiting

Failed medical therapy - GERD symptoms that persist despite 4-8 weeks of twice-daily PPI therapy 1

Severe erosive esophagitis - After 2 months of PPI therapy to assess healing and exclude Barrett esophagus (no repeat endoscopy needed if Barrett is absent) 1

Recurrent dysphagia - In patients with history of esophageal stricture 1

Conditional Indications

Screening for Barrett esophagus/esophageal adenocarcinoma - Consider in men >50 years with chronic GERD (>5 years duration) PLUS multiple risk factors 1:

  • Nocturnal reflux symptoms
  • Hiatal hernia
  • Elevated BMI
  • Tobacco use
  • Intra-abdominal fat distribution

Important caveat: Do NOT screen women of any age or men <50 years routinely, as cancer incidence is very low in these populations 1

Barrett surveillance - In patients with known Barrett esophagus without dysplasia, perform surveillance every 3-5 years; more frequent intervals required with dysplasia 1

Inappropriate Indications

Do NOT perform upper endoscopy for 1, 2:

  • Isolated dyspepsia without adequate PPI trial (4-8 weeks)
  • Mild-moderate reflux responding to lifestyle changes and antacids
  • Asymptomatic patients with history of esophageal stricture
  • Known duodenal ulcer responding to treatment
  • Typical irritable bowel syndrome symptoms

Common Upper Endoscopy Diagnoses

The diagnostic yield for appropriate indications is approximately 70% 2. Most common findings include 3, 4:

Inflammatory conditions (most prevalent):

  • Gastritis - 33-45% of cases, most common finding overall
  • GERD/Esophagitis - 9-18%
  • Peptic ulcer disease - 15% (duodenal ulcer 10%, gastric ulcer component)

Structural abnormalities:

  • Esophageal varices - 7-30% (higher in cirrhotic populations)
  • Hiatal hernia - common but often incidental
  • Barrett esophagus - 10% of chronic heartburn patients

Neoplastic lesions:

  • Gastric cancer - 2.9-3.3%
  • Esophageal cancer - 6% (higher in Eastern/Southern Africa at 10%)
  • Gastric polyps - 6%

Normal findings - 22-30% of procedures 4

Lower Endoscopy (Colonoscopy) Indications

Standard Indications

Screening and surveillance 5:

  • Colorectal cancer screening (age-appropriate)
  • Surveillance after polyp removal
  • Inflammatory bowel disease monitoring

Diagnostic indications 6:

  • Severe hematochezia - After excluding upper GI source (10-15% of severe lower GI bleeding is from upper source)
  • Iron deficiency anemia - Unexplained, after negative upper endoscopy
  • Chronic diarrhea - Especially with inflammatory markers
  • Suspected IBD - Based on symptoms and elevated fecal calprotectin

Important: In severe hematochezia with hemodynamic instability, consider upper endoscopy FIRST, as 10-15% have upper GI source 6

Acute Severe Colitis Exception

Flexible sigmoidoscopy (not full colonoscopy) is safer in acute severe colitis due to perforation risk 7. Avoid phosphate enemas and oral sodium phosphate preparations in this setting.

Common Lower Endoscopy Diagnoses

Colonoscopy is now the most common endoscopic procedure in the US (53-58% of all endoscopies) 3. Diagnostic yield approximately 75% 8.

Most common findings 8, 3:

  • Colorectal polyps - 30% (most common lower GI finding)
  • Diverticulosis - 22%
  • Inflammatory bowel disease - 10% (Crohn's disease, ulcerative colitis)
  • Colorectal cancer - 7%
  • Colitis (various etiologies)
  • Angiodysplasia - Most common in cecum/ascending colon (54%)

Quality Considerations

Complete examination standards 5:

  • Cecal intubation rate should exceed 90%
  • Photo-documentation of landmarks mandatory
  • Adequate mucosal visualization (>75% minimum standard)
  • Biopsy protocols must be followed for specific conditions

Common pitfalls to avoid:

  • Performing endoscopy without adequate PPI trial in uncomplicated dyspepsia
  • Screening women or young men for Barrett esophagus without appropriate risk factors
  • Repeat endoscopy after negative Barrett screening
  • Full colonoscopy in acute severe colitis (use sigmoidoscopy instead)
  • Missing upper GI source in severe hematochezia

Biopsy requirements 5:

  • Gastric ulcers: Always biopsy and re-evaluate in 6-8 weeks after H. pylori treatment
  • Barrett esophagus: Seattle protocol when no lesions visible
  • Suspected celiac disease: Minimum 4 biopsies from second duodenum plus 1 from bulb
  • Malignant-appearing lesions: Minimum 6 biopsies
  • Eosinophilic esophagitis: Two different esophageal regions in dysphagia without other cause

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.